Ardent Health closed at $12.99 on Nov 4, up 10.93%, 11.5% below its 52-week closing high. Volume of 1.1M shares was 2.20× its 20-day average (well above normal).
Split-adjusted performance: +21.6% over one month, +38.6% over six months, -11.5% over one year.
In the quarter ended Jun 30, 2026, revenue was $1.62B, down 1.4% from a year earlier, with a net margin of 1.0%.
Short interest was 3.8M shares at the Oct 15 settlement, down 19.0% from the prior report (16.3% of float, 6.8 days to cover).